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LETTERS TO THE EDITOR 
We are pleased to receive Letters to the Editor on appropriate subjects. These letters should be submitted 
in typewritten form, double-spaced, and are not to exceed 2' /2 pages. When appropriate, we wi ll solicit com-
ments from the original authors . All Letters to t he Editor are subject to editing and possible abridgment. 
TYROSINE HYDROXYLATION 
To the Editor: 
In their article, Drs. Shapiro et a l [1] published some rather ques-
tionable conclusions based on data which migh t seem convincing to 
t hose not fam iliar with the field , a nd which I fee l need some clarifica-
tion. In t heir paper, they claimed their data supported the notion that 
mammalia n tyrosinase (EC 1.I4.18.1) was incapable of tyrosine hydrox-
y lation as determined by the tritiated water assay developed by Pom-
erantz [2]. There are a variety of papers in the li terature, some of ours 
included, which have shown 'Purified mammalian tyrosinase to be 
capable of tyrosine hydroxylation, not only via the Pomerantz assay, 
but by several other types of methodologies as well [3-7]. Space does 
not allow a full critique of the paper-however, the inability of t he 
Shapiro group to confirm this may be due to one 01' more of t he 
fo llowing major considerations: 
1. The tyrosine level used in their assay (0.66 mM) has been shown 
to be inhibitory by several workers-the safest levels of tyros ine to use 
to a void competitive inhibition is a full order of magnitude less [3,8,9]. 
2. And more importantly, however, was the fact that the ir enzyme 
preparation most probably contained little 01' no tyrosinase. In our 
earlier paper [8] which discussed the purification scheme employed by 
the Patel and Okun group, we showed that t he technique modifications 
that they employed were less than adequate, s ince only about 0.2% of 
the tyrosinase activity was recovered, with a specific activity that was 
reduced, indicating no purification at all. Shapiro et aI, employing those 
same methods for some reason, appeal' to have purified the same 
nontyrosinase prote ins that we had shown by ge l electrophoresis in our 
e arlier paper. A comparison of the impure preparations (cf t heir Fig 1, 
with more than 9 proteins) wit h the clean preparations of the origina l 
Burnett papers will suffice to prove this point. F urt her , a qu ick scan of 
t he literature (Table I) over t he past 15 yr on tyrosinases found in a 
variety of normal and malignant murine systems shows that the relative 
mobilities of the major isozyme (1',) on 7.5% acrylamide ge ls are around 
0.59; on 7% acrylamide ge ls, it moves even faster (R", 0.65). T he 1'2 
isozyme, which is a minor tyrosinase isozyme, is somewhat slower. The 
2 bands purified by S hapiro et a l had relative mobilities significantly 
s lower than that, 0.44 and 0.30, respectively. T his is very close to the 
electrophoretic data for DOPA-positive proteins that we obtained for 
the same preparation in our earlier papttr (0.47 and 0.35); we have no 
idea what proteins these represent-they must be oxid izing in nature 
since we, as well as the Shapiro group, found that. they were capable of 
oxidizing I-DOPA to melanin. It is feasib le t hat these bands represent 
hemoglobin, or a similar protein, which is capable of oxidizing I-DOPA; 
it should not be ignored that both Holstein et al [4] and White a nd Hu 
[5] demonstrat.ed peroxidase in gels which migrated with a relative 
mobility of around .38-thus these ba nds might represent peroxidase 
activity which was incapable of' tyrosine hydroxylation. 
Lastly, it wou ld have been interesting if t.he Shapiro article had 
included data on analogous studies carri ed out on their peroxidase 
enzyme(s), to enable one to see the e lectrophoret.ic characteristics of 
this enzyme(s) and to assure us t hat its proposed tyrosine hydl'oxy lation 
capabilit.y could be determined with this same assay technique. 
Vincen t J. Hearing, P h.D. 
Senior Investiga tor 
D ermatology Branch 
National Cancer Institu te 
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REPLY 
To the Editor: 
The comments of Dr. Hearing are erroneolls and misleading. Some 
TABLE 1. Electrophoretic migration patterns of Inurine tyrosil1.a.ses 
Authors Ref %1' Tissue 1', T, 
BW'nett et a l [10] 7.0 B-16 melanoma .6 1 .5 1 
Burnett et a l [10] 7.0 H arding Passey mela- .62 .52 
noma 
Burnett et a l [10] 7.0 S-91 me lanoma .62 .51 
Holstein et a l [11] 7.0 Coat color mutants .69 .53 
Burnett et a l [12] 7.0 Normal hair bu lbs .70 .54 
Holstein et a l [13] 7.0 Coat color mutants .70 .54 
Miyazaki a nd Seiji [14] 7.0 Harding Passey mela- .63 
noma 
Nishioka et a l [7] 7.0 S-91 melanoma .65 .53 
.65 ± .04 .53 ± .01 
Hearing a nd Ekel [8] 7.5 S-91 melanoma .55 .44 
Eppig and Hearing [1 5] 7.5 Normal epidermis .60 .46 
Eppig and H earing [15] 7.5 S-91 melanoma .61 .46 
K lingler et a l [16] 7.5 B-I6 mela noma .59 .50 
K lingler et a l [16] 7.5 S-91 melanol11a .59 .50 
White a nd Hu [5] 7.5 B-I6 mela noma .60 
H earing et al [6] 7.5 B-16 me la noma .56 .45 
.59 ± .02 .47 ± .03 
Shapi ro et a l [1 ] 7.5 Ha rding-Passey mela· .44 .30 
noma 
All figures are those given by the a ut hor (if none were given, actual ge ls were measllred). Most data represen t the average of many such gels. 
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of t he poin ts he has ra ised have been dealt with in previous published 
exchanges in t he Journal of Investigative Dermatology. 
l. Dr. Hearing sugges ts that our ina bility to demons t.rate hydroxyl-
ation of ty rosine by mamma lian "tyros inase" is re lated to t he use of a 
concentra tion of tyros ine sufficient to pl'Oduce tota l substrate inhibi-
tion. We a re not aware of documentat ion of tolal substrate inhibi tion 
in any enzyme sys t.em. In a previous study [1] we used a range of 
ty rosine concen trations and found that this had no effect on the 
inabili ty of mammalian " tyrosinase" (dopa oxidase) to hydroxylate 
ty ros ine. In addit ion, we repeated experiments in our current study, 
us ing a s imi la r range of ty rosine concentration , without effect on our 
data . Conversely, hydroxylation of tyrosine by mushroom tyrosinase 
was easily demons trab le [2] us ing tYl'Osine cOI1(;entrations eq ua l to 
t hose employed with our mamma lian "tyrosinase" experiments. 
2. Dr. Hearing's a lleged inability to obtain adequate " tyrosinase" 
concentration us ing our method is of no significance and has no bearing 
on our results. His assay system was ambiguous, and his method of 
differentiating peroxidase from "tyrosinase" activi ty was without value 
for reasons cited previous ly r3l In our previous experiments [2] and in 
t he cunent s tudy, our enzyme preparat.ion (mammalian "tryos inase" ) 
had good specific activity towards dopa, using nonambiguous assay 
methods. 
3. Rx va lue of an enzyme will vary wit.h many facto rs, including its 
polymeric form , binding to other pro te ins [4], and po lymerization time 
used for the gel; pore size will vary with polymerization t ime. Therefore, 
Rx va lue cannot relia bly be used as a pa rameter of enzyme identifica-
t.io n. [t is no t clear why the dopa-positi ve bands he found at t he Rx 
va lues cited in our current study did not represent "tyros inase." We do 
not. understand why Dr. Hearing could suggest that. our dopa-positive 
bands represen ted hemoglobin 01' peroxidase , s ince we clearly sta ted 
t hat t hese bands were diam inobenzidine-negat ive, excluding these pos-
s ibili ties. 
4. Dr. Hearing should be aware t ha t elec trophoretic characteristics 
of melanoma peroxidase cannot be determined, s ince this peroxidase is 
firmly membrane- bound. We make this point in our rebutta l to his 
previous pape r [3]. 
The only way that t he controversy about " tyrosinase" can be re-
solved is by s tep-by-step cl'Ossvel' ifica tion of results, with exchange of 
stal·ting materia ls and in termedia tes between laboratories with con!lict-
ing data, as well as the use of nona mbiguous methods of enzyme assay. 
In recent correspondence we have offered to participate in this cross-
ve rification with Dr. Hearing. It is most unfortuna te that he has 
declined this offer. 
REFERENCES 
1. Edelstein 1M, Cru'iglia N, Okun MR, Patel HP, S mucker D: Inability 
of murine melanoma melanosomal " tyrosinase" (L-dopa ox idase) 
to ox idize tyros ine to melan in in polyacry lam ide ge l systems. J 
Invest Dermalo l 64:364-370, 1975 
2. Pa tel HP, Okun MR, Yee WA, Wilgram GF, Edelstein LM: Inability 
of murine melanoma "tyrosinase" (dopa oxidae) to oxidize ty ro-
s ine in t he presence 01' absence of dopa or dihydl'oxyfumarate 
cofactor. J Invest Dermatol 6 1 :55-59, 1973 
3. Okun MR: Cri tiqu e of Dr. Hearing's paper. J Invest Dermatol 64: 
83-84, 1975 
4. Burnett, J: Persona l communica tion 
Milton R. Okun, M.D. 
Associate Professor 
Tufts University School of Medicine, 
and Leon M. Edelstein, M.D. 
Associate Professor 
Un ivers ity of California School of Medicine (Davis ) 
AUTOSENS ITIZATION TO DNA 
To the Edi to r: 
We read with great in te rest t he article by Pinnas et al [l] reporting 
decreased T -ce lls and posit.ive skin immunoflu orescence in a patient 
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with sensitization to DNA and aUlologous whole b lood. We have 
previously reported similar find ings in 2 patien ts with clinical and 
la bora tory features cons istent with autoerythrocyte sens it iza tion [2]. 
Bo th patients had decreased T-ce ll coun ts. Immunofluorescence of 
involved and uninvolved skin revealed irregular granular depos its of 
[gM at t he de rmal-epidermal borde r of involved s kin only in one 
patien t. Both patien ts had sligh tly depressed complement levels during 
periods of clinical ac tivity. We look forwa rd to add it ional reports on 
skin immunoflu orescence and la borato ry immunologic parameters in 
other patients with s imilal' purpuric disorde rs. 
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To the Edi tor: 
REPLY 
Drs. Krain , Levin, and S chultz describe 2 patients with decreased 
serum complement levels during the period of ecchymoses, a lt hough 
only 1 of the ir pa tien ts had immunofluorescent depos its of IgM without 
complement at the basement membrane in t he ecchymotic al'ea. Fur-
thermore, this patient had evidence a lso of an associa ted immunologic 
disorder, angioimmunoblastic lymph adenopathy in which T-cell defi-
ciency has been reported (Frizzera G, et a i, Am J Med 59:803, 1975). 
Deposits of IgG and IgA have been reported a long the basement 
membrane in a patient with autoerythrocyte sensitization and lymphoid 
in terstitia l pneumon ia (Decoteau W, et aI, Arch In tel'll Med 134:519, 
1974). 
An early case of autoerythrocyte sensitization showed that histamine 
could precipitate purpura and might be important in the pathogenesis 
(Schulma n N, et a i, Clin R es 7:216,1959). More recent.iy , his tamine has 
been shown to facilita te immune complex deposition in patients with 
vasculitis (Braverman I, Yen A, J Invest DerlTlatol 65:105, 1975). 
[n autoe rythrocyte sensitization, les ions could be induced by in t ra-
cutaneous injection of synthetic bradyk inin but not. by histamine (Leiba 
H, lsI' J Med Sci 8:67, 1972) . Our findings of IgM and C" at t he 
derlTlaepiderma l junction in a patien t with au tosensitization to DNA 
was associated with other immunologic abnormalities bu t not with an 
obvious unde rl y ing immunologic disorder. More recently, IgM and Ca 
have been found in vessel walls in t he upper de rmis in a patient with 
purpura associated with erythema chronicum migrans (Gross G, et aI, 
Arch Dermatol 115:873, 1979). We have a lso found immunoglobu lin 
and complement deposits within a lveolar hyaline membranes in idio-
pathic respil'a tory distress synru'ome and group B streptococcal seps is 
during the early neonatal period (Pinnas J , et a i, Pediatrics 63:557, 
1979) . 
It is apparent that a number o f mechanisms assoc iated with inflam-
mation may shal'e a fina l common pathway associated with immune 
complex depos ition in the involved organ. 
Jacob L. Pinnas, M.D. 
Associate Professor 
